Orgenesis Inc (NASDAQ:ORGS) CEO Vered Caplan updates Proactive on ways in which the group is aiming to combat the coronavirus. Caplan spoke to Proactive about its BioShield Program, which is designed to use neutralizing human antibodies as a possible rapid defense and to potentially mitigate the spread of viruses such as the coronavirus that causes the COVID-19 disease.
viewOrgenesis
Orgenesis Inc outlines ways in which the group is aiming to combat the coronavirus
Quick facts: Orgenesis
Price: 6.54 USD
NASDAQ:ORGS
Market: NASDAQ
Market Cap: $157.98 m
Follow
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Orgenesis named herein, including the promotion by the Company of Orgenesis in any Content on the Site, the Company receives from said issuer...
FOR OUR FULL DISCLAIMER CLICK HEREMost read
Finance
LiteLink Technologies signs LOI to complete equity investment in Canadian...
10 hours, 8 minutes ago
Health
Imugene receives approval for phase I clinical trial of new checkpoint...
6 days, 21 hours ago
Retail & consumer
MamaMancini’s Holdings: Meet the team that’s creating a recipe for success...
8 hours, 25 minutes ago
